Molecular lymphangiogenesis: New players

Trends in Cell Biology

Volumn 15, Issue 8, 2005, Pages 434-441

  Tammela, Tuomas ^a   Petrova, Tatiana V ^b   Alitalo, Kari ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ANGIOPOIETIN; ANGIOTENSIN; EPHRIN B2; GROWTH FACTOR; INTEGRIN; NEUROPILIN 2; PDZ PROTEIN; PROTEIN KINASE SYK; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR FOXP3; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 3;

CAPILLARY BASEMENT MEMBRANE; CELL INTERACTION; CELL SURFACE; CELL ULTRASTRUCTURE; CHICK EMBRYO; CHYLOUS ASCITES; GENE TARGETING; HYPOPLASIA; INDUCED MUTATION; LEG EDEMA; LYMPH FLOW; LYMPH NODE HYPERPLASIA; LYMPHANGIECTASIS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; NONHUMAN; ONTOGENY; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 23744484477     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2005.06.004     Document Type: Review

References (89)

1. M.H. Witte Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology Microsc. Res. Tech. 55 2001 122 145
2. G. Oliver, and M. Detmar The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature Genes Dev. 16 2002 773 783
3. F.R. Sabin On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig Am. J. Anat. 1 1902 367 391
4. F.R. Sabin The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole Am. J. Anat. 9 1909 43 91
5. G.S. Huntington, and C.F.W. McClure The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica) Anat. Rec. 2 1910 1 19
6. L.V. Leak Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface Microvasc. Res. 2 1970 361 391
7. K. Pajusola FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines Cancer Res. 52 1992 5738 5743
8. A. Kaipainen Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development Proc. Natl Acad. Sci. U. S. A. 92 1995 3566 3570
9. V. Joukov A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases EMBO J. 15 1996 290 298
10. M.G. Achen Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proc. Natl. Acad. Sci. U. S. A. 95 1998 548 553
11. N. Ferrara The biology of VEGF and its receptors Nat. Med. 9 2003 669 676
12. V. Joukov Proteolytic processing regulates receptor specificity and activity of VEGF-C EMBO J. 16 1997 3898 3911
13. S.A. Stacker Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers J. Biol. Chem. 274 1999 32127 32136
14. G. Siegfried The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis J. Clin. Invest. 111 2003 1723 1732
15. V. Joukov A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities J. Biol. Chem. 273 1998 6599 6602
16. M. Jeltsch Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 276 1997 1423 1425
17. T. Veikkola Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice EMBO J. 20 2001 1223 1231
18. T. Veikkola Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function FASEB J. 17 2003 2006 2013
19. T. Makinen Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 EMBO J. 20 2001 4762 4773
20. S. Banerji LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan J. Cell Biol. 144 1999 789 801
21. S. Breiteneder-Geleff Podoplanin, novel 43-kD membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis Am. J. Pathol. 151 1997 1141 1152
22. E. Kriehuber Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages J. Exp. Med. 194 2001 797 808
23. S. Podgrabinska Molecular characterization of lymphatic endothelial cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 16069 16074
24. T.V. Petrova Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor EMBO. 21 2002 4593 4599
25. S. Hirakawa Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells Am. J. Pathol. 162 2003 575 586
26. M.R. Saban Visualization of lymphatic vessels through NF-κB activity Blood 104 2004 3228 3230
27. J.T. Wigle, and G. Oliver Prox1 function is required for the development of the murine lymphatic system Cell 98 1999 769 778
28. M. Groger IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells J. Immunol. 173 2004 7161 7169
29. M.J. Karkkainen Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins Nat. Immunol. 5 2004 74 80
30. H. Kubo Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea Proc. Natl. Acad. Sci. U. S. A. 99 2002 8868 8873
31. A. Saaristo Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes FASEB J. 16 2002 1041 1049
32. T.V. Byzova Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo Blood 99 2002 4434 4442
33. R. Cao Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability Circ. Res. 94 2004 664 670
34. J.T. Wigle An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype EMBO J. 21 2002 1505 1513
35. Y.K. Hong Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate Dev. Dyn. 225 2002 351 357
36. J. Wilting Lymphangioblasts in embryonic lymphangiogenesis Lymphat. Res. Biol. 1 2003 33 40
37. P. Salven VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells Blood 101 2003 168 172
38. Y. He Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis Cancer Res. 64 2004 3737 3740
39. S-J. Oh VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane Dev. Biol. 188 1997 96 109
40. J.A. Nagy Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis J. Exp. Med. 196 2002 1497 1506
41. Y.K. Hong VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins FASEB J. 18 2004 1111 1113
42. S.F. Schoppmann Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis Am. J. Pathol. 161 2002 947 956
43. C. Cursiefen Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival Invest. Ophthalmol. Vis. Sci. 45 2004 2666 2673
44. P. Baluk Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation J. Clin. Invest. 115 2005 247 257
45. F. Abtahian Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk Science 299 2003 247 251
46. G. Garcia-Cardena Biomechanical activation of vascular endothelium as a determinant of its functional phenotype Proc. Natl. Acad. Sci. U. S. A. 98 2001 4478 4485
47. F. le Noble Flow regulates arterial-venous differentiation in the chick embryo yolk sac Development 131 2004 361 375
48. C.P. Ng Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro Microvasc. Res. 68 2004 258 264
49. T.V. Petrova Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis Nat. Med. 10 2004 974 981
50. S.L. Dagenais Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome Gene Expr. Patterns 4 2004 611 619
51. G. Brice Analysis of the phenotypic abnormalities in lymphoedema- distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24 J. Med. Genet. 39 2002 478 483
52. A. Poliakov Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly Dev. Cell 7 2004 465 480
53. R.H. Adams Vascular patterning by Eph receptor tyrosine kinases and ephrins Semin. Cell Dev. Biol. 13 2002 55 60
54. T. Makinen PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature Genes Dev. 19 2005 397 410
55. V. Schacht T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema EMBO J. 22 2003 3546 3556
56. M.J. Karkkainen Molecular regulation of lymphangiogenesis and targets for tissue oedema Trends Mol. Med. 7 2001 18 22
57. L. Yuan Abnormal lymphatic vessel development in neuropilin 2 mutant mice Development 129 2002 4797 4806
58. D.J. Dumont Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors Oncogene 7 1992 1471 1480
59. P. Saharinen Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2 J. Cell Biol. 169 2005 239 243
60. P.C. Maisonpierre Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 1997 55 60
61. H.J. Lee Biological characterization of angiopoietin-3 and angiopoietin-4 FASEB J. 18 2004 1200 1208
62. N. Jones Tie receptors: new modulators of angiogenic and lymphangiogenic responses Nat. Rev. Mol. Cell Biol. 2 2001 257 267
63. G. Thurston Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis Cell Tissue Res. 314 2003 61 68
64. U. Fiedler The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies Blood 103 2004 4150 4156
65. N.W. Gale Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1 Dev. Cell 3 2002 411 423
66. Tammela, T. et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood (in press)
67. A. Ayadi Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1 EMBO J. 20 2001 5139 5152
68. X.Z. Huang Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1 Mol. Cell. Biol. 20 2000 5208 5215
69. N.E. Vlahakis The lymphangiogenic growth factors VEGF-C and D are ligands for the integrin alpha 9beta 1 J. Biol. Chem. 218 2005 4544 4552
70. J.F. Wang Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration J. Biol. Chem. 276 2001 41950 41957
71. T. Makinen Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 Nat. Med. 7 2001 199 205
72. M.J. Karkkainen Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema Nat. Genet. 25 2000 153 159
73. R. Cao PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis Cancer Cell 6 2004 333 345
74. P. Saharinen Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation Trends Immunol. 25 2004 387 395
75. S.A. Stacker Molecular targeting of lymphatics for therapy Curr. Pharm. Des. 10 2004 65 74
76. K. Pajusola Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors Oncogene 9 1994 3545 3555
77. K. Pajusola Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts Oncogene 8 1993 2931 2937
78. B.K. McColl Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D J. Exp. Med. 198 2003 863 868
79. E. Fournier Mutation at tyrosine residue 1337 abrogates ligand dependent transforming capacity of the FLT4 receptor Oncogene 11 1995 921 931
80. J.F. Wang Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor Blood 90 1997 3507 3515
81. J. Dixelius Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites J. Biol. Chem. 278 2003 40973 40979
82. Y. He Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling J. Natl. Cancer Inst. 94 2002 819 825
83. G.W. Schmid-Schonbein Microlymphatics and lymph flow Physiol. Rev. 70 1990 987 1028
84. S.D. Nathanson Insights into the mechanisms of lymph node metastasis Cancer 98 2003 413 423
85. D.R. Gnepp, and F.H. Green Scanning electron microscopy of collecting lymphatic vessels and their comparison to arteries and veins Scan. Electron Microsc. 1979 1979 756 762
86. K. Iida Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis Development 124 1997 4627 4638
87. B.M. Kriederman FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome Hum. Mol. Genet. 12 2003 1179 1185
88. D. Pennisi Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice Nat. Genet. 24 2000 434 437
89. A.C. Gittenberger-De Groot Abnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema Dev. Dyn. 230 2004 378 384